The Relation Between MiR-125b-5p and Staging of Endometriosis
NCT ID: NCT05556213
Last Updated: 2022-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2020-05-12
2022-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relation Between MicroRNA 203 and 210 and Sparing the Laparoscopic Examination in Cases of Unexplained Infertility
NCT05680350
Evaluation of miRNAs in Endometriosis
NCT04728152
The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis
NCT06168097
Cell Free DNA Quantification in Patients With Endometriosis Followed Witd Medical Assistance to Procreation
NCT05815134
The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA
NCT04598698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
laparoscopic examination
laparoscopic examination for staging of endometriosis
Control
Blood sampling
Blood sample to detect endometriosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laparoscopic examination
laparoscopic examination for staging of endometriosis
Blood sampling
Blood sample to detect endometriosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients who were suspicious of having malignancy elsewhere in the body region,
* pregnant women,
* patients who had diabetes mellitus,
* body mass index (BMI) of \>30 kg/m2, coagulopathies, and autoimmune disorders.
22 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Hagars
Assistant professor of gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university
Tanta, El-Gharbyia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35617/8/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.